Toggle navigation
Menu
About Us
Investment Strategy
Team
Portfolio
News
Contact Us
Limited Partners
Portfolio
Ception Therapeutics
Emerging biopharmaceutical company which develops novel products to address unmet medical needs
Malvern, PA
NASDAQ: CEPH
Contact:
Jeff Himawan
Acquisition
Acquired by: Cephalon, Inc.
Exit date: April 06, 2010
Related News
Teva’s Well-Traveled Asthma Drug Comes Through in Phase III
Cephalon Completes Acquisition of Ception Therapeutics
Cephalon Signs Option Agreement to Acquire Ception Therapeutics